TIMELINE FOR THE DOUBLE ANTIPLATELET THERAPY. FACTS AND SUGGESTIONS
The review article provides with recent data on the crucial cardiology problems — duration of double antiplatelet therapy (DAPT) in patients with different types of ischemic heart disease. The analysis is provided of actual clinical guidelines on this issue, the results of recent clinical trials are...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2016-02-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/520 |
| _version_ | 1797856976622845952 |
|---|---|
| author | O. L. Barbarash V. V. Kashtalap |
| author_facet | O. L. Barbarash V. V. Kashtalap |
| author_sort | O. L. Barbarash |
| collection | DOAJ |
| description | The review article provides with recent data on the crucial cardiology problems — duration of double antiplatelet therapy (DAPT) in patients with different types of ischemic heart disease. The analysis is provided of actual clinical guidelines on this issue, the results of recent clinical trials are highlighted, as of metaanalyses. Based on the results of international trials, the necessity postulated of thorough assessment of risk and safety for either prolongation or shortening of DAPT, and some possible indications provided for these changes in 12-month DAPT. |
| first_indexed | 2024-04-09T20:49:13Z |
| format | Article |
| id | doaj.art-beef3867d9214eaf8fca0c5a6b8b2c01 |
| institution | Directory Open Access Journal |
| issn | 1560-4071 2618-7620 |
| language | Russian |
| last_indexed | 2024-04-09T20:49:13Z |
| publishDate | 2016-02-01 |
| publisher | «FIRMA «SILICEA» LLC |
| record_format | Article |
| series | Российский кардиологический журнал |
| spelling | doaj.art-beef3867d9214eaf8fca0c5a6b8b2c012023-03-29T21:23:25Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202016-02-0102758310.15829/1560-4071-2016-2-75-83499TIMELINE FOR THE DOUBLE ANTIPLATELET THERAPY. FACTS AND SUGGESTIONSO. L. Barbarash0V. V. Kashtalap1Research Institute for Complex Issues of Cardiovascular Diseases; Kemerovo State Medical Academy of the Ministry of HealthResearch Institute for Complex Issues of Cardiovascular Diseases; Kemerovo State Medical Academy of the Ministry of HealthThe review article provides with recent data on the crucial cardiology problems — duration of double antiplatelet therapy (DAPT) in patients with different types of ischemic heart disease. The analysis is provided of actual clinical guidelines on this issue, the results of recent clinical trials are highlighted, as of metaanalyses. Based on the results of international trials, the necessity postulated of thorough assessment of risk and safety for either prolongation or shortening of DAPT, and some possible indications provided for these changes in 12-month DAPT.https://russjcardiol.elpub.ru/jour/article/view/520double antiplatelet therapydurationischemic eventsbleedingsaspirintienopyridines |
| spellingShingle | O. L. Barbarash V. V. Kashtalap TIMELINE FOR THE DOUBLE ANTIPLATELET THERAPY. FACTS AND SUGGESTIONS Российский кардиологический журнал double antiplatelet therapy duration ischemic events bleedings aspirin tienopyridines |
| title | TIMELINE FOR THE DOUBLE ANTIPLATELET THERAPY. FACTS AND SUGGESTIONS |
| title_full | TIMELINE FOR THE DOUBLE ANTIPLATELET THERAPY. FACTS AND SUGGESTIONS |
| title_fullStr | TIMELINE FOR THE DOUBLE ANTIPLATELET THERAPY. FACTS AND SUGGESTIONS |
| title_full_unstemmed | TIMELINE FOR THE DOUBLE ANTIPLATELET THERAPY. FACTS AND SUGGESTIONS |
| title_short | TIMELINE FOR THE DOUBLE ANTIPLATELET THERAPY. FACTS AND SUGGESTIONS |
| title_sort | timeline for the double antiplatelet therapy facts and suggestions |
| topic | double antiplatelet therapy duration ischemic events bleedings aspirin tienopyridines |
| url | https://russjcardiol.elpub.ru/jour/article/view/520 |
| work_keys_str_mv | AT olbarbarash timelineforthedoubleantiplatelettherapyfactsandsuggestions AT vvkashtalap timelineforthedoubleantiplatelettherapyfactsandsuggestions |